In  line  with  its  decentralization  principle,  the  Ethiopian  Health  Policy  has  achieved  great progress  in  improving  access  to  comprehensive  HIV/AIDS  services  to  the  majority  of  the population. Both quality and coverage of services have improved significantlysince the initiation... of the free ART program in 2005. The role of health workforce in general and that of pharmacy professionals assumes a central position in these achievements. To  further  enhance  accessibility  and  quality  of  services,  capacity  buildingof  health  cadres  is critical.  Therefore,  this  comprehensive  HIV  prevention,  care  and  treatment  training  material  is prepared with the primarily intention to build the capacity of pharmacy professionals at all levels so that they can contribute to the provision of HIV services.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma. It is an important public health problem, particularly in poverty-stricken areas, especially those within the tropics and subtropics. It is estimated th...at at least 236 million people worldwide are infected, 90% of them in sub-Saharan Africa, and that this disease causes approximately 300,000 deaths annually. The clinical manifestations are varied and affect practically all organs. There are substantial differences in the clinical presentation, depending on the phase and clinical form of schistosomiasis in which it occurs. Schistosomiasis can remain undiagnosed for a long period of time, with secondary clinical lesion. Here, we review the clinical profile of schistosomiasis. This information may aid in the development of more efficacious treatments and improved disease prognosis.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Baseado no livro Preparación y respuesta ante la eventual introducción del virus chikungunya en las américas
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                www.thelancet.com/infection Vol 15 February 2015
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Los Marcos de Referencia para la Formación en Residencias Médicas constituyen una herramienta central del proceso de armonización de la formación en residencias en tanto establecen los componentes mínimos que tienen que estar presentes en la formación.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America and the Pediatric Infectious Diseases Society
(This g...uideline was simultaneously published in The Pediatric Infectious Disease Journal on November 6, 2013.)
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Communicable Disease Control Branch
Communicable Disease Management Protocol – Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS), February 2010
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                PLOS ONE | https://doi.org/10.1371/journal.pone.0196239 April 23, 2018
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Ce document présente des recommandations sur les soins cliniques et le dépistage du virus chez les survivants de la maladie à virus Ebola. Il s'adresse principalement aux professionnels de santé qui dispensent des soins primaires aux personnes ayant survécu.
Table des matières
...
1. Introduction
2. Planifier le suivi d'un survivant
3. Séquelles courantes de la maladie à virus Ebola et recommandations pour l’évaluation et la prise en charge
4. Considérations pour les populations spéciales
5. Surveillance de l’infection due à la persistance du virus Ebola chez les survivants
6. Considérations sur la prévention et le contrôle de l’infection chez les survivants
7. Considérations relatives à la communication des risques
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                29 Dec 2021. Comprehensive slideset updated regularly to include the latest data and guidance on best practices for COVID-19 diagnosis and prevention of COVID-19 transmission.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Handbook of Foodborne Pathogenic Microorganisms and Natural Toxins
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Participant Manual September 2009
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.